Pages that link to "Q40582817"
Jump to navigation
Jump to search
The following pages link to Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines. (Q40582817):
Displaying 50 items.
- MSH3 mismatch repair protein regulates sensitivity to cytotoxic drugs and a histone deacetylase inhibitor in human colon carcinoma cells (Q21133026) (← links)
- Epigenetics of colorectal cancer (Q24598045) (← links)
- Microsatellite instability in colorectal cancer (Q24627393) (← links)
- A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines (Q24792846) (← links)
- Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines (Q24799458) (← links)
- Implications of mismatch repair-deficient status on management of early stage colorectal cancer (Q26772272) (← links)
- Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer (Q28080176) (← links)
- PAK6 increase chemoresistance and is a prognostic marker for stage II and III colon cancer patients undergoing 5-FU based chemotherapy (Q28252178) (← links)
- Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1 (Q28283017) (← links)
- Cancer drug resistance: an evolving paradigm (Q29616694) (← links)
- Brother of Regulator of Imprinted Sites (BORIS) suppresses apoptosis in colorectal cancer. (Q30354418) (← links)
- Inter-relationship between microsatellite instability, thymidylate synthase expression, and p53 status in colorectal cancer: implications for chemoresistance (Q33245747) (← links)
- Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2 (Q33521938) (← links)
- Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer (Q33586020) (← links)
- DNA methylation of developmental genes in pediatric medulloblastomas identified by denaturation analysis of methylation differences (Q33591795) (← links)
- DNA polymerases as potential therapeutic targets for cancers deficient in the DNA mismatch repair proteins MSH2 or MLH1 (Q33754229) (← links)
- The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside (Q33762979) (← links)
- Genomic and epigenetic instability in colorectal cancer pathogenesis (Q33836026) (← links)
- Clement Richard Boland, Jr., MD: a conversation with the editor. Interview by William Clifford Roberts (Q33945019) (← links)
- Clinical relevance of microsatellite instability in colorectal cancer (Q33990921) (← links)
- 5-Fluorouracil response in a large panel of colorectal cancer cell lines is associated with mismatch repair deficiency (Q34059750) (← links)
- Clinicopathological features and microsatellite instability (MSI) in colorectal cancers from African Americans. (Q34138105) (← links)
- Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas (Q34170505) (← links)
- Development of sporadic microsatellite instability in colorectal tumors involves hypermethylation at methylated-in-tumor loci in adenoma (Q34254446) (← links)
- Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor (Q34408875) (← links)
- Drug resistance in cancer: an overview. (Q34437369) (← links)
- Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management. (Q34713100) (← links)
- DNA repair mechanisms in dividing and non-dividing cells (Q34727858) (← links)
- Pathologic Factors Associated with Prognosis after Adjuvant Chemotherapy in Stage II/III Microsatellite-Unstable Colorectal Cancers (Q35198960) (← links)
- Anticipation in lynch syndrome: where we are where we go (Q35560811) (← links)
- Incorporating Basic Nutrition Science into Health Interventions for Cancer Prevention (Q35579950) (← links)
- Proximal versus distal hyperplastic polyps of the colorectum: different lesions or a biological spectrum? (Q35587994) (← links)
- Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive, and therapeutic implications (Q35836592) (← links)
- DNA methylation of hMLH1 correlates with the clinical response to cisplatin after a surgical resection in Non-small cell lung cancer (Q35854212) (← links)
- Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of Colorectal Cancer Cell Lines to Identify Novel Biomarkers (Q35871650) (← links)
- mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer (Q36103305) (← links)
- Microsatellite instability testing and its role in the management of colorectal cancer. (Q36124008) (← links)
- Oncologic management of hereditary colorectal cancer (Q36178242) (← links)
- Long-lasting reduction in clonogenic potential of colorectal cancer cells by sequential treatments with 5-azanucleosides and topoisomerase inhibitors. (Q36194410) (← links)
- Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome (Q36246500) (← links)
- Lynch syndrome (hereditary non-polyposis colorectal cancer): current concepts and approaches to management (Q36259687) (← links)
- Molecular classification and correlates in colorectal cancer (Q36329300) (← links)
- Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications (Q36396727) (← links)
- DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines (Q36465214) (← links)
- Predictive markers for the response to 5-fluorouracil therapy in cancer cells: Constant-field gel electrophoresis as a tool for prediction of response to 5-fluorouracil-based chemotherapy (Q36475888) (← links)
- A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency (Q36494964) (← links)
- Mismatch repair defects and Lynch syndrome: The role of the basic scientist in the battle against cancer (Q36540568) (← links)
- Links between biology, prognosis and prediction of response to chemotherapy in colorectal cancer. (Q36549454) (← links)
- Epigenetic diagnostics of cancer--the application of DNA methylation markers (Q36667457) (← links)
- Chemotherapeutic implications in microsatellite unstable colorectal cancer (Q36693771) (← links)